Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 146 | 152 | PF00089 | 0.522 |
CLV_NRD_NRD_1 | 305 | 307 | PF00675 | 0.554 |
CLV_NRD_NRD_1 | 311 | 313 | PF00675 | 0.621 |
CLV_NRD_NRD_1 | 46 | 48 | PF00675 | 0.609 |
CLV_PCSK_KEX2_1 | 148 | 150 | PF00082 | 0.402 |
CLV_PCSK_KEX2_1 | 305 | 307 | PF00082 | 0.481 |
CLV_PCSK_KEX2_1 | 58 | 60 | PF00082 | 0.673 |
CLV_PCSK_PC1ET2_1 | 148 | 150 | PF00082 | 0.444 |
CLV_PCSK_PC1ET2_1 | 58 | 60 | PF00082 | 0.609 |
CLV_PCSK_PC7_1 | 301 | 307 | PF00082 | 0.508 |
CLV_PCSK_PC7_1 | 54 | 60 | PF00082 | 0.608 |
CLV_PCSK_SKI1_1 | 145 | 149 | PF00082 | 0.433 |
CLV_PCSK_SKI1_1 | 30 | 34 | PF00082 | 0.624 |
CLV_PCSK_SKI1_1 | 321 | 325 | PF00082 | 0.531 |
CLV_Separin_Metazoa | 230 | 234 | PF03568 | 0.517 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.709 |
DEG_SPOP_SBC_1 | 41 | 45 | PF00917 | 0.556 |
DOC_CKS1_1 | 135 | 140 | PF01111 | 0.475 |
DOC_CYCLIN_RxL_1 | 27 | 36 | PF00134 | 0.623 |
DOC_MAPK_gen_1 | 226 | 234 | PF00069 | 0.576 |
DOC_PP4_FxxP_1 | 10 | 13 | PF00568 | 0.624 |
DOC_USP7_MATH_1 | 314 | 318 | PF00917 | 0.640 |
DOC_USP7_MATH_2 | 256 | 262 | PF00917 | 0.478 |
DOC_USP7_UBL2_3 | 90 | 94 | PF12436 | 0.473 |
DOC_WW_Pin1_4 | 134 | 139 | PF00397 | 0.461 |
DOC_WW_Pin1_4 | 175 | 180 | PF00397 | 0.386 |
DOC_WW_Pin1_4 | 252 | 257 | PF00397 | 0.434 |
LIG_14-3-3_CanoR_1 | 134 | 138 | PF00244 | 0.452 |
LIG_14-3-3_CanoR_1 | 149 | 157 | PF00244 | 0.233 |
LIG_14-3-3_CanoR_1 | 233 | 240 | PF00244 | 0.553 |
LIG_14-3-3_CanoR_1 | 259 | 266 | PF00244 | 0.494 |
LIG_14-3-3_CanoR_1 | 278 | 287 | PF00244 | 0.603 |
LIG_14-3-3_CanoR_1 | 59 | 63 | PF00244 | 0.593 |
LIG_14-3-3_CterR_2 | 342 | 346 | PF00244 | 0.750 |
LIG_BRCT_BRCA1_1 | 6 | 10 | PF00533 | 0.706 |
LIG_Clathr_ClatBox_1 | 32 | 36 | PF01394 | 0.576 |
LIG_deltaCOP1_diTrp_1 | 81 | 89 | PF00928 | 0.467 |
LIG_FHA_1 | 12 | 18 | PF00498 | 0.694 |
LIG_FHA_1 | 122 | 128 | PF00498 | 0.398 |
LIG_FHA_1 | 176 | 182 | PF00498 | 0.412 |
LIG_FHA_1 | 187 | 193 | PF00498 | 0.523 |
LIG_FHA_1 | 27 | 33 | PF00498 | 0.424 |
LIG_FHA_1 | 279 | 285 | PF00498 | 0.475 |
LIG_FHA_2 | 200 | 206 | PF00498 | 0.491 |
LIG_FHA_2 | 253 | 259 | PF00498 | 0.446 |
LIG_FHA_2 | 41 | 47 | PF00498 | 0.677 |
LIG_LIR_Apic_2 | 151 | 157 | PF02991 | 0.383 |
LIG_LIR_Apic_2 | 7 | 13 | PF02991 | 0.523 |
LIG_LIR_Gen_1 | 177 | 186 | PF02991 | 0.357 |
LIG_LIR_Gen_1 | 81 | 89 | PF02991 | 0.481 |
LIG_LIR_Nem_3 | 126 | 131 | PF02991 | 0.354 |
LIG_LIR_Nem_3 | 177 | 183 | PF02991 | 0.366 |
LIG_LIR_Nem_3 | 286 | 290 | PF02991 | 0.495 |
LIG_LIR_Nem_3 | 81 | 86 | PF02991 | 0.514 |
LIG_LIR_Nem_3 | 87 | 92 | PF02991 | 0.516 |
LIG_LRP6_Inhibitor_1 | 113 | 119 | PF00058 | 0.536 |
LIG_Pex14_2 | 71 | 75 | PF04695 | 0.443 |
LIG_SH2_CRK | 110 | 114 | PF00017 | 0.347 |
LIG_SH2_CRK | 69 | 73 | PF00017 | 0.449 |
LIG_SH2_PTP2 | 244 | 247 | PF00017 | 0.421 |
LIG_SH2_SRC | 154 | 157 | PF00017 | 0.470 |
LIG_SH2_SRC | 166 | 169 | PF00017 | 0.501 |
LIG_SH2_STAP1 | 110 | 114 | PF00017 | 0.357 |
LIG_SH2_STAP1 | 123 | 127 | PF00017 | 0.394 |
LIG_SH2_STAT3 | 130 | 133 | PF00017 | 0.384 |
LIG_SH2_STAT5 | 123 | 126 | PF00017 | 0.394 |
LIG_SH2_STAT5 | 128 | 131 | PF00017 | 0.358 |
LIG_SH2_STAT5 | 154 | 157 | PF00017 | 0.470 |
LIG_SH2_STAT5 | 166 | 169 | PF00017 | 0.354 |
LIG_SH2_STAT5 | 244 | 247 | PF00017 | 0.386 |
LIG_SH3_1 | 191 | 197 | PF00018 | 0.455 |
LIG_SH3_3 | 103 | 109 | PF00018 | 0.424 |
LIG_SH3_3 | 191 | 197 | PF00018 | 0.436 |
LIG_SH3_3 | 222 | 228 | PF00018 | 0.438 |
LIG_SH3_4 | 94 | 101 | PF00018 | 0.434 |
LIG_TRAF2_1 | 255 | 258 | PF00917 | 0.522 |
MOD_CDK_SPxxK_3 | 252 | 259 | PF00069 | 0.430 |
MOD_CK1_1 | 20 | 26 | PF00069 | 0.630 |
MOD_CK1_1 | 326 | 332 | PF00069 | 0.553 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.675 |
MOD_CK2_1 | 199 | 205 | PF00069 | 0.486 |
MOD_CK2_1 | 252 | 258 | PF00069 | 0.450 |
MOD_Cter_Amidation | 56 | 59 | PF01082 | 0.604 |
MOD_GlcNHglycan | 19 | 22 | PF01048 | 0.536 |
MOD_GlcNHglycan | 215 | 218 | PF01048 | 0.508 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.718 |
MOD_GlcNHglycan | 316 | 319 | PF01048 | 0.526 |
MOD_GlcNHglycan | 326 | 329 | PF01048 | 0.474 |
MOD_GSK3_1 | 129 | 136 | PF00069 | 0.514 |
MOD_GSK3_1 | 156 | 163 | PF00069 | 0.353 |
MOD_GSK3_1 | 16 | 23 | PF00069 | 0.674 |
MOD_GSK3_1 | 319 | 326 | PF00069 | 0.565 |
MOD_N-GLC_1 | 278 | 283 | PF02516 | 0.582 |
MOD_N-GLC_1 | 314 | 319 | PF02516 | 0.682 |
MOD_N-GLC_1 | 324 | 329 | PF02516 | 0.650 |
MOD_N-GLC_1 | 338 | 343 | PF02516 | 0.626 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.671 |
MOD_NEK2_1 | 160 | 165 | PF00069 | 0.361 |
MOD_NEK2_1 | 17 | 22 | PF00069 | 0.579 |
MOD_NEK2_1 | 186 | 191 | PF00069 | 0.535 |
MOD_NEK2_1 | 323 | 328 | PF00069 | 0.515 |
MOD_NEK2_1 | 338 | 343 | PF00069 | 0.577 |
MOD_NEK2_2 | 123 | 128 | PF00069 | 0.487 |
MOD_NEK2_2 | 199 | 204 | PF00069 | 0.603 |
MOD_PIKK_1 | 129 | 135 | PF00454 | 0.472 |
MOD_PIKK_1 | 148 | 154 | PF00454 | 0.304 |
MOD_PIKK_1 | 278 | 284 | PF00454 | 0.608 |
MOD_PKA_1 | 148 | 154 | PF00069 | 0.522 |
MOD_PKA_1 | 47 | 53 | PF00069 | 0.645 |
MOD_PKA_1 | 58 | 64 | PF00069 | 0.405 |
MOD_PKA_2 | 11 | 17 | PF00069 | 0.720 |
MOD_PKA_2 | 133 | 139 | PF00069 | 0.460 |
MOD_PKA_2 | 148 | 154 | PF00069 | 0.367 |
MOD_PKA_2 | 258 | 264 | PF00069 | 0.487 |
MOD_PKA_2 | 58 | 64 | PF00069 | 0.576 |
MOD_Plk_4 | 123 | 129 | PF00069 | 0.385 |
MOD_Plk_4 | 319 | 325 | PF00069 | 0.574 |
MOD_ProDKin_1 | 134 | 140 | PF00069 | 0.454 |
MOD_ProDKin_1 | 175 | 181 | PF00069 | 0.381 |
MOD_ProDKin_1 | 252 | 258 | PF00069 | 0.434 |
MOD_SUMO_rev_2 | 40 | 50 | PF00179 | 0.694 |
TRG_DiLeu_BaEn_1 | 168 | 173 | PF01217 | 0.380 |
TRG_DiLeu_BaEn_1 | 230 | 235 | PF01217 | 0.511 |
TRG_DiLeu_BaLyEn_6 | 27 | 32 | PF01217 | 0.651 |
TRG_DiLeu_LyEn_5 | 230 | 235 | PF01217 | 0.511 |
TRG_ENDOCYTIC_2 | 110 | 113 | PF00928 | 0.365 |
TRG_ENDOCYTIC_2 | 244 | 247 | PF00928 | 0.386 |
TRG_ENDOCYTIC_2 | 69 | 72 | PF00928 | 0.449 |
TRG_ER_diArg_1 | 277 | 280 | PF00400 | 0.501 |
TRG_ER_diArg_1 | 304 | 306 | PF00400 | 0.526 |
TRG_Pf-PMV_PEXEL_1 | 233 | 237 | PF00026 | 0.451 |
TRG_Pf-PMV_PEXEL_1 | 238 | 243 | PF00026 | 0.421 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PED1 | Leptomonas seymouri | 83% | 100% |
A0A0S4J0P0 | Bodo saltans | 59% | 100% |
A0A1X0NM32 | Trypanosomatidae | 70% | 100% |
A0A3R7MQ73 | Trypanosoma rangeli | 69% | 100% |
A0A3S7XB37 | Leishmania donovani | 100% | 100% |
A4HPF7 | Leishmania braziliensis | 92% | 100% |
D0A3H0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 65% | 99% |
E9AT69 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
Q4Q1C8 | Leishmania major | 98% | 100% |
V5BPU3 | Trypanosoma cruzi | 68% | 100% |